Peptide Decoding
New?New to peptides?Start here →
Decoding

Larazotide_

Also known as AT-1001, larazotide acetate, INN-202

An oral peptide studied for sealing a leaky gut, mainly in celiac disease.

Gut / leaky gutTight-junction regulatorInvestigational
Dose0.5 mg per dose
FrequencyBefore meals
RouteBy mouth (oral)
StatusInvestigational
CycledNot cycled in the trials

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

01

What is Larazotide?

Plain language first. The technical label stays, but it never stands alone.

Overview

Larazotide is an 8-amino-acid peptide that tightens the junctions between the cells lining your gut. In plain terms: it works locally in the intestine to seal a 'leaky' gut barrier and has been studied mainly for celiac disease. It is not absorbed into the body.

What it's used for

An oral peptide studied for sealing a leaky gut lining, mainly for celiac disease. It works in the gut and is not absorbed.

02

How does Larazotide work?

What it does in the body, and where.

Larazotide is unusual here: it is designed specifically not to be absorbed. It works on the inside surface of your gut and never enters the bloodstream.

  1. 01
    It tightens the junctions between gut lining cells
    The seals between cells that determine what can pass from the gut into the body.
  2. 02
    It works in the gut cavity, not in your blood
    Which limits both its effects and its risks to the intestine itself.
  3. 03
    Celiac disease is what it was built for
    Reducing the symptoms that break through when someone eating gluten-free encounters small amounts anyway.
  4. 04
    Phase 3 did not meet its endpoint
    It has been through large trials, which is more than most compounds here can say, and it did not clearly work.
Where it acts
Gut

Where this compound is thought to act.

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Celiac disease symptoms despite a gluten-free diet, where the Phase 3 trial was stopped in 2022 for lack of benefitInvestigational
  • Sealing a leaky gut lining generallyEarly research
04

How much, and do you cycle it?

The range, and whether you take breaks.

0.5 mg per dose, before meals. Not cycled in the trialsTrial dose

In the trials this was given continuously for the whole study period. No on/off schedule has been tested, so there is nothing to report beyond that.

Compare cycling across compounds →

05

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Larazotide is not injected

It is taken by mouth (oral).

Cost per month
Cost per dose
Typical dose
500 mcg–500 mcg / doseTrial dose
06

How do you store it?

Before mixing, and after.

Room temperature. Cool, dry, out of light.

Larazotide is taken as a pill or capsule. Keep it in its original container at room temperature, away from heat, humidity, and direct sun. No fridge or mixing needed. Check the expiration date on the bottle.

07

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • No formal contraindications established

Stop and get help

These are emergencies. Seek care.
  • Signs of an allergic reaction

Common effects

Expected, and usually mild.
  • Comparable to placebo in trials, since it works in the gut and is not absorbed
  • Its Phase 3 celiac trial was stopped in 2022 because it did not work well enough, not because it was unsafe

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

08

Is Larazotide approved?

And where the numbers on this page come from.
Investigational

No. Not FDA-approved.

It is still being studied; a regulator has not cleared it for this use.

  • DoseFrom published clinical trials. Not approved by a regulator for this dose.
  • Vial sizeFrom what vendors typically list; not a recommendation.
  • Reviewed22 July 2026
10

What these words mean

Show glossary +
Titrate
Starting at a low dose and increasing it slowly over time so your body adjusts and side effects stay mild.
Subcutaneous
An injection just under the skin, into the fat layer, usually with a short, thin insulin needle.
Intramuscular (IM)
An injection into a muscle, using a longer needle.
Reconstitution
Mixing a powdered peptide with liquid (bacteriostatic water) so it can be drawn into a syringe.
Bacteriostatic water
Sterile water with a tiny amount of preservative, used to mix powdered peptides.
Concentration
How strong the mixed peptide is, in milligrams per milliliter (mg/mL). More water makes it weaker; less water makes it stronger.
Units (on the syringe)
The marks on an insulin syringe. 100 units equals 1 mL. They measure how much liquid you draw, not the dose in milligrams.
mcg and mg
Units of dose. 1 milligram (mg) equals 1,000 micrograms (mcg).
GLP-1
A natural gut hormone that lowers appetite and blood sugar. Drugs that copy it, like semaglutide, are used for weight loss.
Growth hormone secretagogue
A compound that nudges your body to release more of its own growth hormone, rather than injecting the hormone itself.
Half-life
How long a compound stays active in your body. A longer half-life means you inject less often.
Peptide vs small molecule
A peptide is a short chain of amino acids. A few items here (like MK-677 or methylene blue) are small molecules, not true peptides, but people use them the same way.
Research only
No approved dose or use in people. Sold for research and not reviewed by the FDA for safety or quality.
Investigational
Still being tested in clinical trials and not yet approved or legally sold for general use.
Banned in drug-tested sport
Prohibited by the World Anti-Doping Agency (WADA); using it can disqualify a competing athlete.

Last reviewed 22 July 2026